Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0860
-0.0040 (-4.44%)
Jan 30, 2026, 2:45 PM AEST
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 108.11 million as of January 29, 2026. Its market cap has decreased by -39.97% in one year.
Market Cap
108.11M
Enterprise Value
87.23M
Revenue
3.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 108.11M, an increase of 511.64%. That is a compound annual growth rate of 7.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 108.11M | -3.23% |
| Dec 31, 2025 | 111.71M | -37.97% |
| Dec 31, 2024 | 180.10M | 72.28% |
| Dec 29, 2023 | 104.54M | 574.83% |
| Dec 30, 2022 | 15.49M | -17.41% |
| Dec 31, 2021 | 18.76M | 22.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 143.05M |
| Starpharma Holdings | 142.77M |
| Island Pharmaceuticals | 104.93M |
| Imugene | 102.33M |
| Proteomics International Laboratories | 100.01M |
| LTR Pharma | 99.90M |
| Alterity Therapeutics | 87.00M |
| EZZ Life Science Holdings | 86.32M |